(415) 419-5450

February 17, 2023 Apellis Pharmaceuticals, Inc. (Waltham, MA) today announced that the U.S. FDA has approved SYFOVRE™ (pegcetacoplan...

January 28, 2022 Genentech, a member of the Roche Group, today announced that the FDA has approved Vabysmo™ (faricimab-svoa) for the...

September 1, 2019 Anti-VEGF therapy for exudative macular degeneration places a significant treatment burden both upon patients who must...

November 11, 2017 The MUST trial compared the effectiveness of systemic therapy vs. fluocinolone acetonide implant for severe uveitis. ...

May 4, 2016 5-Year Data from the CATT trial has now become available. The study showed that vision gains secondary to bevacizumab or...

November 13, 2015 Protocol S of the DRCR.net study group is a randomized multi-center clinical trial to evaluate noninferiority of...

March 25, 2015 "Diabetes is a serious public health crisis, affecting more patients every year," Edward Cox, MD, MPH, director of the...

December 15, 2014 Based on the phase 3 RISE/RIDE trials, which show meaningful improvements in diabetic retinopathy in Lucentis-treated...

February 2014 The Argus II retinal prosthesis is 3 x 5 mm and surgically implanted onto the surface of the retina, where it acts to...

January 2014 Five patients with LCA2 had improved visual function within a few months after treatment with a single unilateral injection...